Croda International (LON:CRDA) had its target price increased by research analysts at Morgan Stanley from GBX 4,550 ($62.86) to GBX 4,800 ($66.32) in a research note issued to investors on Friday. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 5.54% from the stock’s current price.
A number of other equities research analysts also recently issued reports on CRDA. Deutsche Bank upped their price target on shares of Croda International from GBX 4,000 ($55.26) to GBX 4,300 ($59.41) and gave the company a “hold” rating in a research note on Thursday, March 1st. Berenberg Bank upped their price target on shares of Croda International from GBX 5,000 ($69.08) to GBX 5,050 ($69.77) and gave the company a “buy” rating in a research note on Thursday, March 1st. Credit Suisse Group upped their price target on shares of Croda International from GBX 3,400 ($46.97) to GBX 3,600 ($49.74) and gave the company an “underperform” rating in a research note on Wednesday, February 28th. Barclays upped their price target on shares of Croda International from GBX 4,700 ($64.94) to GBX 4,900 ($67.70) and gave the company an “overweight” rating in a research note on Wednesday, February 28th. Finally, Liberum Capital reaffirmed a “hold” rating and set a GBX 4,300 ($59.41) price target on shares of Croda International in a research note on Monday, February 26th. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of GBX 4,379.09 ($60.50).
Croda International (LON:CRDA) opened at GBX 4,548 ($62.84) on Friday. Croda International has a 1-year low of GBX 3,461 ($47.82) and a 1-year high of GBX 4,668 ($64.49). The company has a market cap of $5,980.00 and a price-to-earnings ratio of 2,540.78.
Croda International (LON:CRDA) last released its earnings results on Tuesday, February 27th. The company reported GBX 179 ($2.47) EPS for the quarter, topping the consensus estimate of GBX 173.50 ($2.40) by GBX 5.50 ($0.08). Croda International had a net margin of 17.16% and a return on equity of 37.33%. The firm had revenue of GBX 137.31 billion for the quarter.
In other news, insider Steve Foots sold 21,181 shares of the company’s stock in a transaction dated Monday, March 5th. The shares were sold at an average price of GBX 4,434 ($61.26), for a total value of £939,165.54 ($1,297,548.41). In the last three months, insiders bought 11 shares of company stock worth $49,010.
TRADEMARK VIOLATION NOTICE: This news story was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.thelincolnianonline.com/2018/03/18/croda-international-crda-pt-raised-to-gbx-4800.html.
Croda International Company Profile
Croda International Plc creates, makes and sells specialty chemicals. It operates through four segments. The Personal Care segment focuses on ingredients for skin, hair, sun and color cosmetic products. Its portfolio includes anti-ageing ingredients for skin, conditioning agents for hair care and metal oxides for ultraviolet (UV) filters.
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.